Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma (PRP) injections successfully treated a woman's steroid-resistant hair loss, causing hair to regrow within a month.

Fexofenadine may help treat a difficult type of hair loss.

A patient with a rare chromosome condition also had a rare type of hair loss.

Alopecia areata is unpredictable, with limited treatment effectiveness, especially in severe cases.

Researchers identified a new hair loss pattern called "sisaipho type," where hair is lost across the scalp except around the edges.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

The patient with total hair loss did not regrow hair despite treatment, indicating a poor outlook for this type of hair loss.

A man had an unusual type of hair loss that didn't match known patterns and didn't improve with treatment.

Juvenile alopecia areata is more severe and has a worse prognosis than maturity-onset alopecia areata.

Alopecia areata mainly affects young people, often showing as patchy hair loss on the scalp.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Psychological stress is a major factor in the onset and severity of alopecia areata, with atopic individuals being more prone to develop it.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Early recognition and treatment of atypical alopecia areata in infants are crucial.

Microneedling with triamcinolone helps hair regrowth in ophiasis alopecia areata.

Unani medicine may help treat a rare, hard-to-treat hair loss pattern in children.

A 10-year-old girl with hair and eyelash loss showed significant regrowth after treatment.

Alopecia areata is more common in young Black African males, with rare other health issues.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Less than a quarter of alopecia areata cases were unusual forms or had paradoxical regrowth.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Salmon patches on the neck may relate to the severity and recurrence of alopecia areata.

Atopic diseases worsen alopecia areata, leading to earlier onset and more severe forms.

AB+ blood group is more common in alopecia areata patients.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Low serum ferritin levels are linked to more severe and longer-lasting alopecia areata in children.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.